Background illustration for clinical trials search

Multiple Myeloma Clinical Trials

Browse 1,243 multiple myeloma clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer

for
Stage III Thymoma AJCC v8, Stage IIIA Thymoma AJCC v8,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT03295227

Phase1, Recruiting

Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer

for
Anatomic Stage III Breast Cancer AJCC v8,
Location: Boston MA, Mineola NY, New York NY, Columbus OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05422794

Phase1, Recruiting

Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy

for
Large B-Cell Lymphoma With IRF4 Rearrangement,
Location: Jacksonville FL, La Crosse WI, Eau Claire WI,
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06834373

Phase2, Recruiting

Limited-duration Teclistamab

for
Myeloma Multiple
Location: New York NY, Philadelphia PA, Iowa City IA,
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: All

Age: 18+

Code: NCT05932680

Phase2, Recruiting

Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure

for
Heart Failure, Heart Failure NYHA Class II,
Location: Jacksonville FL, Tampa FL, Clearwater FL,
Sponsor: CVRx, Inc.

Sex: All

Age: 18+

Code: NCT07232030

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer

for
Anatomic Stage III Breast Cancer AJCC v8,
Location: Atlanta GA
Sponsor: Emory University

Sex: Female

Age: 18+

Code: NCT05741164

Phase2, Recruiting

Efficacy and Safety of a Botanical Total Coumarin (TC) Cream in Treating Patients With Psoriasis Vulgaris (PLANTCOAT-III)

for
Psoriasis Vulgaris, Topical Administration, Phase III
Location: New York NY
Sponsor: Psoriasis Research Institute of Guangzhou

Sex: All

Age: 18 - 70

Code: NCT07426120

Phase3, Recruiting

Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial

for
Advanced Hepatocellular Carcinoma,
Location: Boston MA, Waterford CT, Guilford CT, Glastonbury CT,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT07166406

Phase3, Recruiting

CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer

for
FIGO Stage III and IV Ovarian Cancer, Fallopian Tube Cancers,
Location: New York NY, Durham NC, Rochester MN, Irvine CA,
Sponsor: TORL Biotherapeutics, LLC

Sex: Female

Age: 18 - 70+

Code: NCT07322094

Phase1, Phase2, Recruiting

Symptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous Melanoma

for
Cutaneous Melanoma, Cutaneous Melanoma, Stage III,
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 18+

Code: NCT07148245

Recruiting

Propensity-Matched Study of Cardiac Contractility Modulation Therapy in Heart Failure

for
Heart Failure and Reduced Ejection Fraction,
Location: Marlton NJ
Sponsor: Impulse Dynamics

Sex: All

Age: 18+

Code: NCT07209098

Recruiting

Safety and Efficacy of ONT01 in Lupus

for
Lupus Nephritis (LN), Lupus Nephritis - WHO Class III,
Location: New York NY
Sponsor: Hospital for Special Surgery, New York

Sex: All

Age: 18+

Code: NCT07107659

Early_phase1, Recruiting

NORM-HF Pivotal Study

for
Heart Failure, NYHA Class III Heart Failure,
Location: Philadelphia PA, Jacksonville FL, Tampa FL,
Sponsor: Foundry Innovation & Research 1, Limited (FIRE1)

Sex: All

Age: 18+

Code: NCT07574593

Recruiting

HEME Home Transfusion Program

for
Leukemia, Myeloma, Myelodysplastic Syndromes,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT06487247

Recruiting

PREcision MEDicine In Achalasia (PREMEDIA) - Cohort

for
Type III Achalasia,
Location: Boston MA, Charlotte NC, Gainesville FL, Cleveland OH,
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT07293689

Recruiting

Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Juxtarenal Aortic Aneurysms

for
Technical Sucess,
Location: Springfield MA
Sponsor: Baystate Medical Center

Sex: All

Age: 18+

Code: NCT07019454

Recruiting

Study of Cannabidiol in Sanfilippo Syndrome

for
Sanfilippo Syndrome, Mucopolysaccharidosis III
Location: Torrance CA
Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Sex: All

Age: 4+

Code: NCT06333041

Phase2, Phase3, Recruiting

Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer

for
Anatomic Stage III Breast Cancer AJCC v8,
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute

Sex: All

Age: 18+

Code: NCT06434064

Phase2, Recruiting

Radioimmunotherapy (111Indium/225Actinium-DOTA-daratumumab) for the Treatment of Relapsed/Refractory Multiple Myeloma

for
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT05363111

Phase1, Recruiting

Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients With Stomach or Other Solid Tumors

for
Clinical Stage III Gastric Cancer AJCC v8,
Location: Houston TX
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06364410

Phase1, Recruiting